According to aforementioned evidence in AAV and atherosclerosis, CD4+ TEM cells are considered to play a pivotal role in the pathogenesis of vascular inflammation and therefore, may serve as a potential therapeutic target. The gene discussed is CD4; the disease is atherosclerosis.